EUVIMEDEUVIMED entdecken
Crossref

Differential NADP-Dependent Isocitrate Dehydrogenases Expression in Metabolically Healthy Obesity vs Metabolic Syndrome: A Probable Predictive Biomarker for Metabolic Deterioration

Mona M Watany iD, Marwa M Elhosary

The Journal of Applied Laboratory Medicine · 2025

DOI: 10.1093/jalm/jfaf124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2025. Verfasst von Mona M Watany und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pathology and Laboratory Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Metabolic Syndrome, Obesity, Metabolically Benign, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nicotinamide adenine dinucleotide phosphate (NADP)-dependent isocitrate dehydrogenases, isocitrate dehydrogenase enzyme (IDH)1 and IDH2, are crucial to normal glucose and lipid metabolism and to oxidative species handling. This study aimed to assess the probability of utilizing NADP-dependent isocitrate dehydrogenases deficiency as a biomarker of the progression of metabolically healthy obesity (MHO) to metabolic syndrome (MetS).

Methods

The study enrolled 120 participants. We investigated IDH1 and IDH2 mRNA expression in peripheral whole blood samples collected from 40 MetS patients, 40 individuals with MHO, and 40 healthy controls, in relation to serum NADP-dependent isocitrate dehydrogenases activity, serum leptin, adiponectin, high-sensitivity C-reactive protein (hs-CRP), and calculated Homeostatic Model Assessment for Insulin Resistance (HOMA-IR).

Results

IDH1 mRNA expression was significantly lower in MetS patients compared to MHO in whom the transcript levels were indifferent from the controls. IDH2 was more deficient in MetS than MHO, and both were lower than controls. Serum NADP-dependent IDH enzyme activity was remarkably lower in the MetS group compared to the MHO group as well as to controls (2.83 ± 0.47 mU/mL, 4.58 ± 0.67 and 6.09 ± 0.93, respectively, P < 0.001). Both transcripts showed strong negative correlations to HOMA-IR, adiposity biomarkers, and hs-CRP. Regression analysis demonstrated that for every 10% decrease in IDH1 and IDH2 transcription, the odds of developing obesity-associated MetS increases by 4.9- and 6.3-fold, respectively.

Conclusions

In contrast to MHO, both IDH1 and IDH2 are deficient in MetS. Their deficiency coincides with chronic inflammation, adipose tissue dysfunction, and insulin resistance. Our preliminary data support the potential use of NADP- dependent IDH as a predictive biomarker of obesity-related MetS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Isocitrate DehydrogenaseMetabolic SyndromeObesity, Metabolically BenignObesityHumansMaleFemaleBiomarkersMiddle AgedAdultInsulin ResistanceCase-Control StudiesLeptinAdiponectinC-Reactive ProteinRNA, Messenger

Substanzen

Isocitrate DehydrogenaseBiomarkersIDH2 protein, humanIDH1 protein, humanLeptinAdiponectinC-Reactive ProteinRNA, Messenger

Autor:innen und Institutionen

  • Clinical Pathology and Laboratory Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
  • Faculty of Science, Tanta University, Tanta, Egypt.

ORCID-Profile: Mona M Watany

Zitieren

APA

Watany, M. M., & Elhosary, M. M. (2025). Differential NADP-Dependent Isocitrate Dehydrogenases Expression in Metabolically Healthy Obesity vs Metabolic Syndrome: A Probable Predictive Biomarker for Metabolic Deterioration. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfaf124

Vancouver

Watany MM, Elhosary MM. Differential NADP-Dependent Isocitrate Dehydrogenases Expression in Metabolically Healthy Obesity vs Metabolic Syndrome: A Probable Predictive Biomarker for Metabolic Deterioration. The Journal of Applied Laboratory Medicine. 2025. doi:10.1093/jalm/jfaf124

BibTeX
@article{Watany2025,
  author = {Watany, Mona M and Elhosary, Marwa M},
  title = {Differential NADP-Dependent Isocitrate Dehydrogenases Expression in Metabolically Healthy Obesity vs Metabolic Syndrome: A Probable Predictive Biomarker for Metabolic Deterioration},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2025},
  doi = {10.1093/jalm/jfaf124}
}
Kostenlos starten →